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ABSTRACT The survival of Plasmodium spp. within the host red blood cell (RBC)
depends on the function of a membrane protein complex, termed the Plasmodium
translocon of exported proteins (PTEX), that exports certain parasite proteins, collec-
tively referred to as the exportome, across the parasitophorous vacuolar membrane
(PVM) that encases the parasite in the host RBC cytoplasm. The core of PTEX con-
sists of three proteins: EXP2, PTEX150, and the HSP101 ATPase; of these three pro-
teins, only EXP2 is a membrane protein. Studying the PTEX-dependent transport of
members of the exportome, we discovered that exported proteins, such as ring-
infected erythrocyte surface antigen (RESA), failed to be transported in parasites in
which the parasite rhoptry protein RON3 was conditionally disrupted. RON3-deﬁcient
parasites also failed to develop beyond the ring stage, and glucose uptake was sig-
niﬁcantly decreased. These ﬁndings provide evidence that RON3 inﬂuences two
translocation functions, namely, transport of the parasite exportome through PTEX
and the transport of glucose from the RBC cytoplasm to the parasitophorous vacuo-
lar (PV) space where it can enter the parasite via the hexose transporter (HT) in the
parasite plasma membrane.
IMPORTANCE The malarial parasite within the erythrocyte is surrounded by two
membranes. Plasmodium translocon of exported proteins (PTEX) in the parasite vacu-
olar membrane critically transports proteins from the parasite to the erythrocytic cy-
tosol and membrane to create protein infrastructure important for virulence. The
components of PTEX are stored within the dense granule, which is secreted from
the parasite during invasion. We now describe a protein, RON3, from another inva-
sion organelle, the rhoptry, that is also secreted during invasion. We ﬁnd that RON3
is required for the protein transport function of the PTEX and for glucose transport
from the RBC cytoplasm to the parasite, a function thought to be mediated by PTEX
component EXP2.
KEYWORDS PTEX, malaria, parasite proteins, parasitophorous vacuolar space
Malaria is a deadly infectious disease caused by parasites of Plasmodium spp. thatin the asexual phase of their life cycle infect and replicate within red blood cells
(RBCs). In a Plasmodium-infected RBC, the parasite is surrounded by the parasito-
phorous vacuolar membrane (PVM) that forms initially from the erythrocyte membrane
during parasite invasion (1). The RBC has little biosynthetic capacity, and for essential
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functions, the parasite must export a subset of its own proteins, termed the exportome,
across the PVM into the RBC cytoplasm and to the RBC membrane. These transported
proteins are needed to build the protein infrastructure required for parasite functions
essential for their pathological survival in the vertebrate host, including remodeling of
the RBC membrane to express receptors for endothelial ligands that sequester infected
RBCs in host tissue, thereby avoiding elimination by the spleen. Protein export across
the PVM involves ATP-dependent protein unfolding and transport; this process is
mediated by a channel assembled in the PVM referred to as the Plasmodium translocon
of exported proteins (PTEX) (2). The core components of PTEX are heat shock protein
101 (HSP101) ATPase, which can unfold proteins, and a transmembrane funnel com-
prised of oligomeric exported protein 2 (EXP2) and PTEX150; genetic interference of
any one of the three PTEX components destroys its function (3, 4). Independent of
these discoveries is the identiﬁcation of a sequence in the N termini of exportome
proteins called the Plasmodium export element (PEXEL) or host-targeting (HT) motif
that is recognized by an aspartic protease, plasmepsin V; this has been shown to clip
off the motif before the protein destined for export associates with PTEX (5, 6).
However, the PEXEL motif is not always required for export, as evidenced by exported
proteins lacking a PEXEL motif (termed PEXEL-negative exported proteins or PNEPs) (7).
A major advance in understanding the mechanism of protein transport by PTEX is the
recent structural determination by cryo-electron microscopy of a puriﬁed PTEX complex
that included EXP2, HSP101 ATPase, and PTEX150 (8). This puriﬁed PTEX complex, in
both an “engaged” state and a “resetting” state, shows EXP2 forming a transmembrane
funnel-shaped protein-conducting channel tethered to the HSP101 ATPase that powers
protein translocation by a ratchet-like translocation mechanism. These ﬁndings ele-
gantly conﬁrmed that PTEX was indeed the site of parasite proteins passing from the
parasitophorous vacuolar (PV) space to the erythrocyte cytoplasm.
Parasite metabolism within the infected RBC also requires the import of nutrients
across the PVM. A nutrient-permeable channel in the PVM proposed to facilitate
passage of nutrients of size as large as 1,400 daltons from the RBC into the PV space
was ﬁrst described by Desai and colleagues (9, 10). Recent studies identify EXP2 as such
a channel, permeable to both amino acids and glucosamine (11). However, EXP2 also
functions independently of HSP101 ATPase activity, indicating that the EXP2 nutrient-
permeable channel complex may not be identical to the EXP2-PTEX channel. Indeed,
there is little precedent for channels that function to transport both proteins and
nutrients. It is possible that EXP2 functions alone, in a complex with PTEX, or with
non-PTEX components to transport nutrients.
In the present study, we describe the surprising ﬁnding that a conditional knockout
(KO) of the misnamed rhoptry neck protein 3 (RON3) caused the early death of the
parasite with an inability of ring-infected erythrocyte surface antigen (RESA), a protein
in the dense granule, to be transported across the PVM into the RBC cytoplasm. In
addition, import of glucose across the PVM to the parasite was signiﬁcantly decreased
in RON3-deﬁcient parasites. RON3 is a protein found in the body of the rhoptries, not
within the rhoptry neck as suggested by the name (12, 13), and is secreted into the
space around the parasite during invasion. The RON3 sequence contains a signal
sequence and three predicted transmembrane sequences, two of which are closely
apposed and one further C-terminal (see Fig. S1 in the supplemental material) (12). All
three transmembrane sequences include a single positively charged residue that may
reﬂect a special role for RON3.
RESULTS
To investigate the role of RON3 in the Plasmodium falciparum life cycle, we condi-
tionally disrupted the gene in the 3D7 parasite clone 1G5DC using the dimerizable P1
bacteriophage cyclization recombination (DiCre) recombinase system (14). Two forms
of RON3loxP were created by clustered regularly interspaced short palindromic repeat
(CRISPR)/CRISPR-associated protein-9 (Cas9)-mediated gene editing, whereby the locus
of X-over P1 (loxP) sites were inserted into different segments of the RON3 gene. The
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RON3 gene contains eight exons with the signal sequence located in exon 1. For version
1 (v1), the RON3 gene was modiﬁed such that exons 2 to 6 were recodonized without
introns between them. This was ﬂanked by synthetic introns containing loxP sites
(Fig. 1A). In version 2 (v2), RON3 was edited further toward the 3= end of the gene by
replacing exons 6 to 7 with a recodonized version containing no introns. The endog-
enous introns on either side of exons 6 to 7 were replaced with synthetic loxP-
containing introns (Fig. 1C).
Disruption of the RON3 gene was induced in ring-stage parasites; excision of the
gene is mediated by brief rapamycin treatment, allowing the activation of the Cre
recombinase that recognizes loxP sequences by dimerization of the DiCre components
(14). Rapamycin treatment was predicted to lead to the excision of the recodonized
exons. In v1, this would eliminate the ﬁrst two transmembrane domains, while in v2,
this would lead to excision of the third transmembrane domain. Diagnostic PCR, using
DNA extracted from dimethyl sulfoxide (DMSO)- or rapamycin-treated v1 (clones 3E10
and 7C4) and v2 (clone B11), showed the expected loss of the intervening recodonized
FIG 1 Rapid and efﬁcient conditional disruption of the P. falciparum RON3 gene. The native PfRON3 gene on chromosome 12 comprises
8 exons (indicated as gray boxes) and 7 introns. (A) Version 1 (v1). Schematic representation of pre- and postintegration events after
CRISPR-Cas9 editing to produce the modiﬁed RON3loxP and the expected locus architecture before and after rapamycin treatment (pre-
and postexcision). Recodonized exons 2 to 6 are shown as a green box. Red arrows indicate target areas of primers RON3_exon1_F (solid
arrow)/RON3_exon7_R (dashed arrow). (B) PCR RON3loxP v1 clones 3E10 and 7C4 were treated with DMSO (D) or rapamycin (R), and
schizonts were analyzed 44 h after treatment to determine excision. DNA markers (M) ranged from 200 to 10,000 bp. Excision leads to
a decrease in amplicon size from 1,615 bp to 422 bp. (C) Version 2 (v2). Schematic representation of pre- and postintegration events after
CRISPR-Cas9 editing to produce the modiﬁed RON3loxP and the expected locus architecture before and after rapamycin treatment (pre-
and postexcision). Recodonized exons 6 to 7 are shown as a yellow box. Blue arrows indicate target areas of primers RON3_exon4_F (solid
arrow)/RON3_exon8_R (dashed arrow). (D) PCR RON3loxP v2 clone B11 was treated with DMSO (D) or rapamycin (R); excision leads to s
decrease in amplicon size from 2,364 bp to 757 bp. DNA markers (M) ranged from 250 to 10,000 bp. Samples were run in duplicate on
the same gel, with the white line indicating splicing of the image to show only one replicate.
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sequence (Fig. 1B and D); v2 parasites were further sequenced, conﬁrming the excision
after rapamycin treatment and demonstrating efﬁcient excision of the ﬂoxed sequences
(data not shown).
Rapamycin-treated v1 or v2 parasites were observed to progress normally through
the cycle in which they were treated (cycle 1; Fig. 2A and B). However, following
invasion into cycle 2, rapamycin-treated parasites did not develop beyond the ring
stage (Fig. 2A, B, and D). Comparison of ring-stage parasites at 94 h was found to be
signiﬁcantly different between treatment conditions (P 0.001). Examination of the
invasion capacity of v1 parasites (clones 3E10 and 7C4) found that rapamycin-treated
parasites invaded new RBCs at a similar rate to DMSO-treated parasites of the same
clone (Fig. 2C). The parental parasite clone, 1G5DC, was also included in these exper-
iments to assess whether rapamycin treatment itself could affect invasion; this con-
ﬁrmed that there were no signiﬁcant differences between DMSO and rapamycin
treatment as previously shown (14). To rule out any effects of loxP insertion, growth
rates were compared between v1 parasites and the parental clone (1G5DC) with no
signiﬁcant differences observed (P 0.05; see Fig. S2 in the supplemental material).
To seek insights into the development defect in cycle 2 rings derived from the
rapamycin-treated RON3loxP parasites, we examined the fate of the PTEX exported
proteins RESA, knob-associated histidine-rich protein (KAHRP), and Maurer’s cleft-
associated histidine-rich protein 1 (MAHRP1) (Fig. 3); RESA was of particular interest, as
it is known to be exported early during ring stages (15). In DMSO-treated RON3loxP
parasites, RESA was found distributed throughout the infected RBC, concentrating in
the space below the RBC membrane, as is normal (16, 17). In contrast, in newly formed
rings of both v1 and v2 excised parasites, RESA was found surrounding the parasite,
FIG 2 RON3-deﬁcient parasites invade normally but stall at the ring stage. (A and B) Version 1 (v1) clone 7C4 (A) or version 2 (v2) clone
B11 (B) parasites were treated with DMSO or rapamycin (Rapa) for 4 h during ring stage and allowed to mature and progress into the next
cycle. Microscopic images of Giemsa-stained thin blood smears were taken at 46 h, 52 h, 72 h, and 94 h following the commencement of
cycle 1. Images are representative of at least three independent experiments. (C) v1 clones 7C4 and 3E10 and the parental line, 1G5DC,
were treated with DMSO or rapamycin to investigate invasive capacity after loss of RON3. Schizonts were puriﬁed after treatment and
allowed to undergo egress and invasion into fresh RBCs for 4 h before ring-stage parasitemia was determined by ﬂow cytometry. Data
were averaged from three biological replicate experiments, using blood samples from different donors. Values are means  1 standard
deviation (error bars). Statistical signiﬁcance was determined by a two-tailed t test where P 0.05 is considered nonsigniﬁcant (ns). (D)
Differential count of the DMSO- or rapamycin-treated v2 B11 parasite blood stages (rings, trophozoites, or schizonts) at 46 h, 52 h, and
94 h. Percentages of each blood stage (rings, trophozoites, or schizonts) were normalized to total percentage parasitemia at each time
point. Data represent two independent experiments, and error bars depict standard deviations (SD).
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indicating failure of translocon function for protein export to the RBC (Fig. 3A and B).
In addition, KAHRP, the electron-dense histidine-rich protein that normally localizes to
below the knobs on the RBC surface, and MAHRP1, located at Maurer’s clefts, remained
close to the parasite and were not translocated to the erythrocyte cytoplasm (Fig. 3A).
Further analysis with antibodies to other exported proteins showed that the rapamycin-
treated parasites were incapable of exporting other parasite proteins (skeleton binding
protein 1 [SBP1], histidine-rich protein 2 [HRP2], and P. falciparum erythrocyte mem-
brane protein 1 [PfEMP1]; Fig. S3). Furthermore, in addition to RESA, the PTEX translo-
con components, EXP2 and PTEX150 (Fig. 3A), were detected in both DMSO- and
rapamycin-treated parasites. EXP2, alongside the other PTEX components, are found in
the dense granules (18) and allow the export of proteins, such as RESA, in healthy
(normal) parasites.
To examine whether loss of RON3 also interfered with import of molecules into
parasitized cells (a function of EXP2 in a role independent of the PTEX complex [11]),
an assay was devised to directly detect import of a labeled glucose analogue, 2-(N-(-
7-nitrobenz-2-oxa-1,3-diazol-4-yl)amino)-2-deoxyglucose (2-NBDG). Cells were further
stained with Hoechst 33342 (DNA marker) and MitoTracker Deep Red (mitochondrial
marker), which allowed parasites to be identiﬁed. Study of 2-NBDG uptake was not
interfered with by the use of these two markers as determined using ﬂuorescent
controls (Fig. S4). RON3-deﬁcient intracellular parasites were observed to take up less
glucose than control DMSO-treated counterparts (Fig. 4A and C). After invasion, glucose
uptake into the parasite was signiﬁcantly lower than glucose uptake into the DMSO
control, as quantiﬁed by comparing the mean ﬂuorescent intensity (MFI) of 2-NBDG in
DMSO- and rapamycin-treated parasites, wherein the MFI of background 2-NBDG signal
in the infected RBC was subtracted from the 2-NBDG MFI in the parasite (change in MFI
FIG 3 RON3 is essential for the export of proteins into the infected RBC. Ring infected RBCs from RON3loxP v1 (A)
and v2 (B) parasites were treated with DMSO or rapamycin (Rapa) for 4 h, washed, and cultured in cRPMI for 40
to 44 h. The parasites were ﬁxed and stained with antibodies to RON3, KAHRP, RESA, MAHRP1, EXP2, or PTEX150
antibodies. RON3, KAHRP, and EXP2 staining is shown in green, and RESA, MAHRP1, and PTEX150 staining is shown
in red. The nuclei staining (4=,6=-diamidino-2-phenylindole [DAPI]) is shown in blue. MAHRP1, KAHRP, or RESA was
exported into the DMSO-treated infected RBCs while they appeared to be around the rapamycin-treated parasite.
All images are representative of the majority of parasites over several ﬁelds and/or of three independent
experiments. DIC, differential interference contrast. Bars, 2 m.
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[ΔMFI]) (Fig. 4B). In two independent experiments (Fig. 4C and S5B), the ΔMFI of
rapamycin-treated parasites was signiﬁcantly less than that of the control, suggesting
impairment of glucose uptake through the PVM. We further observed an outlier in the
rapamycin-treated group; this is likely attributable to 2% of parasites not undergoing
excision during rapamycin treatment and has been previously observed in other DiCre
mutants (14). As 2-NBDG is reported to metabolize to a nonﬂuorescent form, we
repeated the experiment with a nonmetabolizable analogue, 6-NBDG (19), and found
that DMSO-treated parasites still signiﬁcantly took up more glucose than the
rapamycin-treated parasites did (Fig. S5C). We further compared the background MFI of
2-NBDG or 6-NBDG in the infected blood cell (Fig. S5D) and found a signiﬁcant
difference between DMSO- and rapamycin-treated conditions. As demonstrated in this
paper, the loss of RON3 leads to no parasite protein export through the PTEX translo-
FIG 4 Glucose uptake is decreased in RON3loxP parasites. The glucose analogue 2-NBDG was used to track glucose
uptake into v2 cycle 2 DMSO- or rapamycin (Rapa)-treated parasites. (A) Representative images of DMSO- and
Rapa-treated parasites after 2 h of incubation with 2-NBDG. Parasites were additionally stained with Hoechst 33342
(DNA marker) and MitoTracker Deep Red (Mito DR), a mitochondrial marker. Bars, 2 m. (B) Example illustration of
strategy for determining change in mean ﬂuorescent intensity (ΔMFI) of 2-NBDG. MFI (green) was measured by ﬁrst
measuring ﬂuorescent intensity attributed to the parasite (red circle as determined by localization with Hoechst/
MitoTracker [blue/red] localization). Background MFI in the blood cell in which the parasite resides (blue circle) was
subsequently subtracted to provide ΔMFI. (C) ΔMFI of 2-NBDG in DMSO-treated and rapamycin-treated ring-stage
parasites (n 35/group). (D) ΔMFI of 2-NBDG in DMSO-treated and rapamycin-treated merozoites was measured
by subtracting background MFI from merozoite MFI. (E) Representative images of DMSO- and Rapa-treated
merozoites stained with 2-NBDG (n 35/group). Data represent the mean  standard error of the mean (SEM).
Statistical signiﬁcance was determined by two-tailed unpaired t test where P 0.05 is considered signiﬁcant (****,
P 0.0001).
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con. The absence of these parasite proteins in the RBC may lead to reduced uptake in
glucose by the infected RBC. However, as there is only 20% reduction in uptake into
the RBC between groups, we do not believe that this difference is enough to explain
the 50% reduction in glucose uptake into the RON3-deﬁcient parasite.
To exclude a role for RON3 in the function of the hexose transporter (HT) that is
located on the parasite plasma membrane (PPM), released merozoites that were treated
with DMSO or rapamycin were investigated. Free rapamycin-treated merozoites were
observed to take up glucose similarly to DMSO-treated parasites (P 0.05; Fig. 4D),
indicating that the HT present on the PPM is functional and exhibits similar activity.
DISCUSSION
A major breakthrough in malarial cell biology was the identiﬁcation of PTEX (2), a
structure in the outer membrane of the PVM surrounding the intraerythrocytic parasite
that transports proteins into the host erythrocyte membrane. The components of the
translocon, including a pore-forming molecule, EXP2, are initially stored in the dense
granules (18), which are structures located toward the apical end of the merozoite.
During invasion, the dense granules release their contents in the space between the
PPM and the invaginated RBC membrane (20), part of which is destined to become the
PVM. Studies have since proven the function of components of the translocon by
knockdown or destabilizing each of the different components of PTEX (3, 4). The
electrophysiology of this vacuolar membrane was ﬁrst studied by Desai et al. (9, 10)
who estimated an upper limit to the size of molecules passing through pores in the
membrane. Garten et al. (11) then conﬁrmed these ﬁndings and identiﬁed this nutrient-
permeable PVM channel as EXP2 by correlating its proteomic expression level with the
probability of electrophysiological pore detection and by correctly predicting changes
in physiological pore properties upon directed mutation of EXP2 as well as by dem-
onstrating the permeability of the electrophysiological pore to small molecules which
may then be imported into the parasite by transporters in the parasite plasma mem-
brane. The critical study was the deﬁnition of its structure by cryo-electron microscopy
that showed a plausible mechanism for the ATP-driven movement of proteins through
the EXP2 pore (8).
Here we determined that another molecule, RON3, is critical for two distinct
functions: export of parasite proteins into the RBC and import of small molecules, such
as glucose, from the RBC to the parasite. The mechanism by which RON3 inﬂuences the
function of PTEX remains to be elucidated, though we speculate that it may either have
direct involvement with the translocon after insertion, play a role in translocon forma-
tion, or have an upstream effect. Evidence that suggests it is not related to sudden
death of the parasite independent of the failure of function of the translocon is related
to the following observations. First, merozoites invade RBCs normally after the loss of
RON3, a complex series of events required by the parasite. Second, merozoites take up
glucose equally in the DMSO- and rapamycin-treated parasites, indicative of a func-
tional hexose transporter in the plasma membrane. Third, the PTEX translocon com-
ponent EXP2 from the parasite’s dense granules appeared to be released from the
parasite although planned electron microscopy is needed to conﬁrm this ﬁnding.
Fourth, the parasite proteins investigated (KAHRP, MAHRP1, SBP1, PfEMP1, and HRP2)
are made in RON3-deﬁcient parasites, although their export to the RBC does not occur.
Using two distinct approaches to gene disruption of RON3, we show that the loss of
RON3 causes the parasite to lose its PTEX function and arrest at an early stage of
development. This is likely due to the limited availability of vital small molecules from
the RBC, such as glucose.
Previous work identiﬁed PfRON3 as an ortholog of Toxoplasma gondii RON3
(TgRON3), a protein identiﬁed in the rhoptry proteome of T. gondii (12, 13). In Plasmo-
dium spp., RON3 is found in the rhoptries (12), completely separate from the dense
granules that house EXP2 and the other PTEX components (18). How RON3 functions
after secretion and the mechanism by which it potentially affects the function of EXP2
or the translocon remains to be studied.
PfRON3 Affects PTEX Function and Glucose Uptake ®
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We can only speculate on the possible functional role of RON3 at this time; we are
intrigued to note that the separation of RON3 and EXP2 would prevent both premature
PTEX cargo discharge and premature dense granule hydration (often a consequence of
ionic permeabilization of dense core secretory systems [e.g., mast cell granules {21}]).
Failure to exocytose the rhoptries would likely halt invasion, and the failure of dense
core granule fusion due to a lack of RON3 seems unlikely. Future imaging studies will
examine the locations of RON3 after parasite entry.
Two of the predicted transmembrane domains within the RON3 sequence lie only
a few amino acids apart (see Fig. S1 in the supplemental material). Unusually, all three
transmembrane domains contain a single positively charged amino acid residue.
Interestingly, TgRON3 has just a single transmembrane domain that also contains a
positively charged amino acid (13). This feature may facilitate the transfer of PTEX into
the PVM or may have a functional role in protein export. In the original description of
the PTEX translocon, RON3 (UniProt gene ID Q8I4R5, PlasmoDB ID PF3D7_1252100) was
coimmunoprecipitated with PTEX150 tagged with hemagglutinin (PTEX150-HA) (2), but
whether RON3 forms part of the translocon or is required for the formation of the
translocon remains to be deﬁned. The importance of RON3 in both translocon activity
and glucose uptake expands the set of questions regarding the details of aspects of
exocytosis, PVM permeability, translocon formation, and small-molecule transport.
MATERIALS AND METHODS
Reagents and antibodies. Oligonucleotide primers were synthesized by Integrated DNA Technol-
ogies (Skokie, IL) or Sigma-Aldrich (St. Louis, MO). Rapamycin was obtained from Sigma-Aldrich and was
prepared in dimethyl sulfoxide (DMSO) as a 50 M stock. WR99210 was obtained from Jacobus
Pharmaceuticals (Princeton, NJ) and stored as 20 M stock in DMSO. 2-(N-(-7-nitrobenz-2-oxa-1,3-diazol-
4-yl)amino)-2-deoxyglucose (2-NBDG), 6-(N-(-7-nitrobenz-2-oxa-1,3-diazol-4-yl)amino)-6-deoxyglucose
(6-NBDG), MitoTracker Deep Red, and Hoechst 33342 were obtained from Thermo Fisher Scientiﬁc
(Waltham, MA). 2-NBDG was stored as 14.6 mM stock in DMSO, 6-NBDG was stored as 5 mM stock
solution, MitoTracker Deep Red was stored as 7.5 M stock in DMSO, and Hoechst 33342 was stored as
20 mM stock solution. All restriction enzymes were obtained from New England Biolabs (Beverly, MA).
Mouse RON3 antibodies (PfRON3_1) were from Takafumi Tsuboi, Ehime University, Japan (12). Other
antibodies were provided by Robin Anders, La Trobe University Australia (anti-RESA monoclonal antibody
[Mab] 28/2) (22), Anthony Holder, The Francis Crick Institute, United Kingdom (UK) (anti-RON3 MAb 1H1),
John Vakonakis, University of Oxford, UK (rabbit anti-MAHRP1) (23), Paul Gilson (rabbit anti-PTEX150) (24),
and Diane Taylor, University of Hawaii USA (anti-KAHRP MAb 89) (25, 26). MAb 7.7, against EXP2, was
from the European Malaria Reagent Repository, contributed by Jana McBride.
P. falciparum culture and transfection. Transgenesis work used the P. falciparum 3D7-derived
DiCre-expressing clone 1G5DiCre (14), also known as 1G5DC. Asexual blood-stage parasites were
continuously cultured in complete medium (cRPMI; Roswell Park Memorial Institute [RPMI] 1640 medium
containing Albumax [Gibco, Grand Island, NY]) and synchronized with 5% D-sorbitol (27). Transfection of
1G5DC was as previously described (28). Brieﬂy, mature schizonts were enriched using Percoll (29) (GE
Healthcare, Chicago, IL) and electroporated using an Amaxa 4D electroporator and P3 Primary cell 4D
Nucleofector X kit L (Lonza, Basel, Switzerland) (14, 30). Drug selection with cRPMI supplemented with
2.5 nM WR99210 was initiated after 48 h posttransfection to allow selection of parasites transfected with
plasmids carrying the human dihydrofolate reductase gene (dhfr) selectable marker. Integrant parasite
clones for version 1 (v1) (3E10 and 7C4) and v2 (B11) were isolated by limiting dilution.
Generation of RON3loxP parasites. Generation of parasites with a ﬂoxed segment of genomic RON3
gene was achieved by using CRISPR/cas9 gene editing. Two versions of the RON3loxP parasite were
designed: version 1 (v1) replaced endogenous RON3 exons 2 to 6 and introns 1 and 6 with recodonized
exons 2 to 6 ﬂanked by synthetic introns (SERA2-loxPint and SUB2-loxPint), and version 2 (v2) replaced
endogenous RON3 exons 6 and 7 and its ﬂanking introns with recodonized exons 6 and 7 and synthetic
loxP containing introns. A double transfection strategy was used, consisting of the dual Cas9- and
sgRNA-encoding pDC2 plasmid (Marcus Lee, Sanger Institute) and a marker-free targeting plasmid
(60 g; pESS_RON3_v1_loxP or pESS_RON3_v2_loxP). All sgRNAs (20 g each) were designed using
EuPaGDT software (31) and generated by annealing complementary primer sequences. DiCre-mediated
modiﬁcation of RON3loxP version 2 (v2) parasites was conﬁrmed by nucleotide sequencing before and
after rapamycin treatment.
Rapamycin treatment of RON3loxP parasites. Recombination between the loxP sites was induced
in synchronized ring-stage parasites by incubation with 100 nM rapamycin for 4 h; concurrently, parasites
received mock treatment with DMSO (vehicle control). Rapamycin was washed out after 4 h with cRPMI,
and parasites were allowed to progress to the next cycle.
Diagnostic PCR detected excision, and sequencing of RON3loxP. DiCre-mediated excision of the
ﬂoxed RON3 exons was detected by PCR analysis of schizont-stage genomic DNA. Genomic DNA (gDNA)
was extracted from schizont-stage cultures treated with DMSO or rapamycin (approximately 42 h after
treatment) using Quick-gDNA MiniPrep (Zymo Research, Irvine, CA) or DNeasy Blood and Tissue kit
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(Qiagen, Los Angeles, CA). PCR was conducted to determine excision events using 400 nM GoTaq Green
Master Mix (Promega, Madison, WI) per the manufacturer’s instructions, with appropriate primers.
Fifteen-microliter PCRs were carried out in a thermocycler, and products were examined by SYBR Safe
(ThermoFisher Scientiﬁc). Primers RON3_exon1_F (5=-AATGGTATAAGCGGTCATTATACAGAAGGTAGG-3=)
and RON3_exon7_R (5=-ACAAGTTGTGATGTTTGTAACCTATGGG-3=) were used to detect excision events in
v1, and RON3_exon5_F (5=-TCATACAGAAAAATATACAGT) and RON3_exon 8_R (5=-TCTCTTTTCAACTCTT
TTTT-3=) were used to detect excision event in v2. The puriﬁed PCR product of v2 was capillary sequenced
with Big-Dye terminator chemistry on an ABI3730xl DNA sequencer (Applied Biosystems, Foster City, CA).
Growth and invasion analysis of RON3loxP. Comparison of growth in v1 and v2 RON3loxP parasites
treated with DMSO or rapamycin was determined by microscopy of Giemsa-stained thin blood ﬁlms. For
differential counts, a minimum of 1,000 cells were counted for each time point. Invasive capacity of v1
RON3loxP parasites was determined using a previously described method (32). Brieﬂy, highly synchro-
nous mature schizonts were Percoll puriﬁed (29) and then added to RBCs to a parasitemia of 1%. After
4 h, the cultures were ﬁxed, enabling the percentage of newly ring-infected RBCs to be determined by
Hoechst staining and analysis by ﬂow cytometry (LSR II [BD Biosciences, San Jose, CA]). Samples were
analyzed using FlowJo software.
Indirect immunoﬂuorescence assays. Indirect immunoﬂuorescence assays (IFAs) were conducted
using RON3loxP v1 (clone 7C4) and v2 (clone B11). For v1 parasites, thin blood ﬁlms of RON3loxP clone
7C4 parasites were air dried and stored at 80°C. The smears were thawed at 37°C and ﬁxed in 4%
paraformaldehyde (PFA) (Electron Microscopy Sciences, Hatﬁeld, PA) for 30 min at room temperature.
The cell membranes were permeabilized with 0.1% Triton X-100 (Sigma-Aldrich) in phosphate-buffered
saline (PBS), for 10 min at room temperature and washed three times in PBS. The slides were blocked in
3% bovine serum albumin (BSA) in PBS for 2 h at room temperature and probed with mouse anti-RON3
(MAb 1H1; 1:100), mouse anti-RESA (1:1,000), mouse anti-KAHRP (1:500), anti-MAHRP1 (1:2,000), anti-
EXP2 (MAb 7.7; 1:100), or anti-PTEX150 (1:100) for 1 h at room temperature. The slides were washed three
times in PBS and probed with 1:8,000 goat anti-mouse Alexa Fluor 488 or 594 for 1 h at room
temperature. After three washes with PBS, the slides were mounted in ProLong Gold Antifade Mountant
with DAPI (Invitrogen, Carlsbad, CA) and sealed with Cytoseal-60 (ThermoFisher Scientiﬁc). Images were
captured at 100/1.45 numerical aperture (NA) with a Nikon Eclipse Ni-E wide-ﬁeld microscope with a
Hamamatsu C11440 digital camera or at 63/1.4NA with a Zeiss laser scanning microscope (LSM) 880
microscope (Zeiss, Oberkochen, Germany) with AiryScan. The captured images were automatically
processed with the Zen software to enhance the optical resolution isometrically by 1.8-fold.
For v2 parasites, thin smears were made on glass slides and air dried. The cells were ﬁxed in 4% PFA
for 10 min at room temperature and permeabilized in 0.1% Triton X-100 for 15 min at room temperature.
The smears were blocked in 5% nonfat milk (LabScientiﬁc, Highlands, NJ) overnight at 4°C. The slides
were incubated with mouse anti-PfRON3_1 (1:250) or mouse anti-RESA (1:1,000) for 1 h at 37°C and
washed three times for 5 min each time with PBS. This was followed by incubation with goat anti-mouse
Alexa Fluor 488 (1:1,000 for anti-RON3) or goat anti-mouse Alexa 594 (1:2,000 for anti-RESA) (Life
Technologies, Carlsbad, CA) at 37°C for 45 min. The smears were washed three times for 5 min each time
with PBS and air dried. The slides were mounted in ProLong Gold Antifade Mountant with DAPI and
viewed at 63/1.4NA with a Zeiss LSM 880 microscope with AiryScan. The captured images were
automatically processed with the Zen software to enhance the optical resolution isometrically by
1.8-fold.
Live imaging of glucose analogue uptake by RON3loxP. Synchronized parasites treated with
rapamycin or DMSO were allowed to mature and progress to the next cycle, at which time they were
passed through a MACS LS column (Miltenyi Biotec, Auburn, CA) to remove remaining schizonts.
Intracellular ring-stage parasites were stained with 100 M 2-NBDG or 6-NBDG and 600 nM MitoTracker
Deep Red for 2 h at 37°C, after which the cells were washed with phenol red-free cRPMI. The procedure
for investigation of merozoites was conducted with the following differences: schizonts were puriﬁed
from cultures and stained with 2-NBDG and MitoTracker Deep Red, which were not washed out after
incubation for 2 h. Cells were dispensed at 0.06% hematocrit to Nunc Lab-Tek II eight-well chamber slides
(ThermoFisher Scientiﬁc) coated with 0.01% poly-L-lysine (Sigma-Aldrich). Prior to imaging, Hoechst
33342 was added to wells at a ﬁnal concentration of 2 M. Cells were imaged by Zeiss LSM 880 (Zeiss,
Oberkochen, Germany); the system was allowed to equilibrate during sample preparation to permit
samples to be maintained at 37°C and an atmosphere of 5% CO2 during imaging. Time between washing
and imaging was kept between 15 and 20 min. Images were captured using a 63/1.4NA plan-
apochromatic objective lens, and intensity information was measured using the Zen software tools.
Further, to account for potential loss of 2-NBDG signal due to metabolism to a nonﬂuorescent form over
time (33), collection of images for each treatment condition were staggered by switching between wells
containing DMSO or rapamycin-treated parasites every ﬁve images. DMSO-treated parasites were
additionally stained with each individual dye to act as ﬂuorescent controls (see Fig. S4 in the supple-
mental material). The captured images were processed and analyzed using the Zen software. Mean
ﬂuorescent intensity (MFI) was measured by ﬁrst measuring ﬂuorescent intensity attributed to the
parasite (as determined by localization with Hoechst/MitoTracker). Background MFI in the blood cell, in
which the parasite resides, was subsequently subtracted to provide the change in MFI (ΔMFI). All imaging
parameters were kept the same during imaging and between duplicate experiments. For analysis of
merozoite intensity, background MFI was measured in the area around the merozoite.
Statistical analysis. All quantitative data were statistically analyzed and graphed using GraphPad
Prism 7 or 8 for Mac. Data are presented as means  standard errors of means (SEM) or standard
deviations (SD). For differential counts of blood stages, each stage (ring, trophozoite, or schizont) was
PfRON3 Affects PTEX Function and Glucose Uptake ®
July/August 2019 Volume 10 Issue 4 e01460-19 mbio.asm.org 9
 o
n
 July 17, 2019 by guest
http://m
bio.asm
.org/
D
ow
nloaded from
 
normalized using the total percentage parasitemia at each particular time point. Unpaired two-tailed t
test was used to determine signiﬁcant differences between groups, with P 0.05 as the threshold for
signiﬁcance.
SUPPLEMENTAL MATERIAL
Supplemental material for this article may be found at https://doi.org/10.1128/mBio
.01460-19.
FIG S1, TIF ﬁle, 0.1 MB.
FIG S2, TIF ﬁle, 0.3 MB.
FIG S3, TIF ﬁle, 0.8 MB.
FIG S4, TIF ﬁle, 0.5 MB.
FIG S5, TIF ﬁle, 0.5 MB.
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